aid: terremoto-biosciences
name: Terremoto Biosciences
description: >-
  Terremoto Biosciences is a privately held, clinical-stage biotechnology company based in South San
  Francisco, California, building a covalent drug discovery and development engine around lysine-based
  covalency. Founded in 2022 by veterans of Principia Biopharma and backed by OrbiMed and Third Rock
  Ventures across Series A ($75M), Series B ($175M) and Series C ($108M) financings, the company designs
  highly selective small-molecule medicines aimed both at improving on known drug targets and at reaching
  targets previously considered undruggable. Its lead program, TER-2013, is an AKT1-selective inhibitor
  granted FDA Fast Track designation for breast cancer, with additional work in oncology and hereditary
  hemorrhagic telangiectasia. Terremoto is a therapeutics developer, not a software vendor: it publishes
  no public API, developer portal, SDK or machine-readable API contract, and its public web surface is a
  corporate marketing site covering science, pipeline, news and careers.
url: https://raw.githubusercontent.com/api-evangelist/terremoto-biosciences/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment
specificationVersion: '0.20'
created: '2026-08-30'
modified: '2026-08-30'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Life Sciences
- Oncology
- Healthcare
- Clinical Stage
- Small Molecule
image: https://terremotobio.com/wp-content/uploads/Terremoto_Footer_Logo.png
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/terremoto-biosciences-domain-security.yml
- type: LLMsTxt
  url: llms/terremoto-biosciences-llms.txt
- type: Website
  url: https://terremotobio.com/
- type: About
  url: https://terremotobio.com/about/
- type: Blog
  url: https://terremotobio.com/news/
- type: Support
  url: https://terremotobio.com/contact/
- type: TermsOfService
  url: https://terremotobio.com/terms-of-use/
- type: PrivacyPolicy
  url: https://terremotobio.com/privacy/privacy-policy/
x-enrichment:
  date: '2026-08-30'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Terremoto Biosciences is a clinical-stage covalent small-molecule drug developer whose entire
    public surface is a WordPress marketing site (science, pipeline, news, careers) — every contract
    probe missed (no OpenAPI/Swagger at the root, no /graphql, no /mcp, no agent card, and none of
    api./developers./docs./portal.terremotobio.com resolve in DNS), leaving only the WordPress CMS's
    own incidental /wp-json/ route index and an All in One SEO-generated llms.txt, neither of which
    is a product API.
  evidence:
  - url: https://terremotobio.com/openapi.json
    status: 404
  - url: https://terremotobio.com/graphql
    status: 404
  - url: https://terremotobio.com/.well-known/agent-card.json
    status: 404
  - url: https://api.terremotobio.com/
    status: 0
  - url: https://terremotobio.com/llms.txt
    status: 200
  - url: https://terremotobio.com/wp-json/
    status: 200
  checked: '2026-08-30'